SXRJ:F:F-iShares VII Public Limited Company - iShares MSCI EMU Small Cap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 314.8

Change

-0.45 (-0.14)%

Market Cap

USD 0.86B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.09 (-0.17%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-3.16 (-0.57%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-0.53 (-0.53%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+15.30 (+6.77%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.72 (-0.57%)

USD 24.77B

ETFs Containing SXRJ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.95% 91% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.95% 90% A- 79% B-
Trailing 12 Months  
Capital Gain 9.15% 71% C- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.15% 69% C- 58% F
Trailing 5 Years  
Capital Gain 73.29% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.29% 70% C- 52% F
Average Annual (5 Year Horizon)  
Capital Gain 7.56% 62% D 61% D-
Dividend Return 7.56% 59% D- 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.60% 30% F 76% C+
Risk Adjusted Return 45.56% 49% F 63% D
Market Capitalization 0.86B 71% C- 55% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.